A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07697456

Title field or adapter rule

{'original_value': "A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis", 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:36.122421+00:00

Published At

2026-10-27T00:00:00+00:00

Record Updated At

2026-10-27

Source Retrieved At

2026-10-31T22:18:58.295941+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Crohn\u0027s Disease", "Ulcerative Colitis"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-27", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07697456"

protocolSection.identificationModule.officialTitle

"A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severely Active Crohn\u0027s Disease or Ulcerative Colitis"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Crohn's Disease (protocolSection.conditionsModule.conditions)
• Ulcerative Colitis (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Substudy 1: CD Arm 1 Risankizumab monotherapy', 'Substudy 1: CD Arm 4 ABBV-466 (Risankizumab/Trosunilimab)', 'Substudy 1: CD Arm 5 ABBV-466 (Risankizumab/Trosunilimab)', 'Substudy 1: UC Arm 1 Risankizumab monotherapy', 'Substudy 1: UC Arm 4 ABBV-466 (Risankizumab/Trosunilimab)', 'Substudy 1: UC Arm 5 ABBV-466 (Risankizumab/Trosunilimab)', 'Substudy 2: CD Arm 1 Risankizumab monotherapy', 'Substudy 2: CD Arm 4 ABBV-7066 (Risankizumab/ABBV-701)', 'Substudy 2: CD Arm 5 ABBV-7066 (Risankizumab/ABBV-701)', 'Substudy 2: CD Arm 6 ABBV-7066 (Risankizumab/ABBV-701)', 'Substudy 2: UC Arm 1 Risankizumab monotherapy', 'Substudy 2: UC Arm 4 ABBV-7066 (Risankizumab/ABBV-701)', 'Substudy 2: UC Arm 5 ABBV-7066 (Risankizumab/ABBV-701)', 'Substudy 2: UC Arm 6 ABBV-7066 (Risankizumab/ABBV-701)'], 'description': 'Intravenous/Subcutaneous/Intramuscular Injection/Infusion', 'name': 'Risankizumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Substudy 1: CD Arm 2 Trosunilimab monotherapy', 'Substudy 1: CD Arm 3 Trosunilimab monotherapy', 'Substudy 1: CD Arm 4 ABBV-466 (Risankizumab/Trosunilimab)', 'Substudy 1: CD Arm 5 ABBV-466 (Risankizumab/Trosunilimab)', 'Substudy 1: UC Arm 2 Trosunilimab monotherapy', 'Substudy 1: UC Arm 3 Trosunilimab monotherapy', 'Substudy 1: UC Arm 4 ABBV-466 (Risankizumab/Trosunilimab)', 'Substudy 1: UC Arm 5 ABBV-466 (Risankizumab/Trosunilimab)'], 'description': 'Intravenous/Subcutaneous/Intramuscular Injection/Infusion', 'name': 'Trosunilimab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Substudy 2: CD Arm 2 ABBV-701 monotherapy', 'Substudy 2: CD Arm 3 ABBV-701 monotherapy', 'Substudy 2: CD Arm 4 ABBV-7066 (Risankizumab/ABBV-701)', 'Substudy 2: CD Arm 5 ABBV-7066 (Risankizumab/ABBV-701)', 'Substudy 2: CD Arm 6 ABBV-7066 (Risankizumab/ABBV-701)', 'Substudy 2: UC Arm 2 ABBV-701 monotherapy', 'Substudy 2: UC Arm 3 ABBV-701 monotherapy', 'Substudy 2: UC Arm 4 ABBV-7066 (Risankizumab/ABBV-701)', 'Substudy 2: UC Arm 5 ABBV-7066 (Risankizumab/ABBV-701)', 'Substudy 2: UC Arm 6 ABBV-7066 (Risankizumab/ABBV-701)'], 'description': 'Intravenous/Subcutaneous/Intramuscular Injection/Infusion', 'name': 'ABBV-701', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Risankizumab (protocolSection.armsInterventionsModule.interventions[].name)
• Trosunilimab (protocolSection.armsInterventionsModule.interventions[].name)
• ABBV-701 (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.